Globeflex Capital L P Alkermes Plc. Transaction History

Globeflex Capital L P

$1.03 Billion
Q3 2024

A detailed history of Globeflex Capital L P transactions in Alkermes Plc. stock. As of the latest transaction made, Globeflex Capital L P holds 19,193 shares of ALKS stock, worth $598,629. This represents 0.05% of its overall portfolio holdings.

Number of Shares

19,193

Previous 19,193 -0.0%

Holding current value

$598,629

Previous $462,000 16.23%

% of portfolio

0.05%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$23.37 - $28.68 $28,674 - $35,190	1,227 Added 6.83%	19,193 $532,000
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $218,338 - $256,910	8,036 Added 80.93%	17,966 $503,000
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $116,729 - $133,840	4,612 Added 86.72%	9,930 $279,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $113,740 - $164,767	5,170 Added 3493.24%	5,318 $119,000
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $602,791 - $697,319	-22,833 Reduced 99.36%	148 $4,000
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $606,856 - $736,276	-26,305 Reduced 53.37%	22,981 $605,000
Q4 2021 Feb 10, 2022	SELL	$21.47 - $32.08 $563,523 - $842,003	-26,247 Reduced 34.75%	49,286 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $175,625 - $241,456	7,515 Added 11.05%	75,533 $2.33 Million
Q2 2021 Aug 12, 2021	BUY	$18.78 - $25.15 $1.28 Million - $1.71 Million	68,018 New	68,018 $1.67 Million
Q2 2020 Aug 12, 2020	SELL	$13.31 - $19.41 $87,832 - $128,086	-6,599 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$13.06 - $21.24 $33,067 - $53,779	2,532 Added 62.26%	6,599 $95,000
Q1 2019 May 10, 2019	BUY	$28.4 - $36.49 $115,502 - $148,404	4,067 New	4,067 $148,000

Others Institutions Holding ALKS

# of Institutions

358

Shares Held

180M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.12B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account

Globeflex Capital L P Alkermes Plc. Transaction History